Literature DB >> 11562626

Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease.

K J Wierenga1, B E Serjeant, G R Serjeant.   

Abstract

Human parvovirus B19 infection causes most clinically defined aplastic crises in homozygous sickle cell (SS) disease. With transfusion support, the outcome is generally benign; however, cerebrovascular complications in close temporal association with B19-induced aplastic crises have been described. We carried out a retrospective review, between 1978 and 1999, of 346 aplastic crises in patients with SS disease attending the Sickle Cell Clinic of the University Hospital of the West Indies, Kingston, Jamaica. Six cerebrovascular episodes, 5 with hemiplegia, occurred within 2 days of aplastic crises; and 4, all with features of encephalitis, occurred within 2 to 5 weeks. Hemiplegia in 2 children resolved completely, one is improving, and one persists 20 years later; one patient died from recurrent strokes. Of the 4 children whose events occurred later, all had seizure disorders and 2 had transient cortical blindness. The crude risk of cerebrovascular episodes in the 5-week interval after B19 infection was calculated as 58 times greater than expected, which is suggestive of a causal association.

Entities:  

Mesh:

Year:  2001        PMID: 11562626     DOI: 10.1067/mpd.2001.117070

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.

Authors:  Jacqueline A Hobbs
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

3.  Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.

Authors:  Jeffrey D Lebensburger; Prasannalaxmi Palabindela; Thomas H Howard; Daniel I Feig; Inmaculada Aban; David J Askenazi
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

4.  Stroke in sickle cell disease in Africa: case report.

Authors:  J Makani
Journal:  East Afr Med J       Date:  2004-12

5.  Parvovirus B19 Infection in Children With Arterial Ischemic Stroke.

Authors:  Heather J Fullerton; Jorge M Luna; Max Wintermark; Nancy K Hills; Rafal Tokarz; Ying Li; Carol Glaser; Gabrielle A DeVeber; W Ian Lipkin; Mitchell S V Elkind
Journal:  Stroke       Date:  2017-09-01       Impact factor: 7.914

6.  The excess burden of stroke in hospitalized adults with sickle cell disease.

Authors:  John J Strouse; Lori C Jordan; Sophie Lanzkron; James F Casella
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

7.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

8.  Acute silent cerebral infarction in children with sickle cell anemia.

Authors:  Michael M Dowling; Charles T Quinn; Zora R Rogers; George R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

Review 9.  Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children.

Authors:  Toru Watanabe; Hideshi Kawashima
Journal:  World J Clin Pediatr       Date:  2015-11-08

10.  Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum.

Authors:  James K Grant; Natalie C Yin; Annette M Zaytoun; Hena Waseem; Jacqueline A Hobbs
Journal:  Cerebellum       Date:  2009-07-08       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.